Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F

Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe

(2018) Hadis Honarvar et al.   Scientific Reports

Targeting HER2 in Nuclear Medicine for Imaging and Therapy

(2018) Adriana V. F. Massicano et al.   Molecular Imaging

89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

(2018) Frederike Bensch et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

(2017) Gary A. Ulaner et al.   JOURNAL OF NUCLEAR MEDICINE

SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe99mTc-HYNIC-H6F in Breast Cancer Mouse Models

(2017) Liqiang Li et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison of Contrast-Enhanced CT and [18F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer

(2017) Franca Wagner et al.   MOLECULAR IMAGING AND BIOLOGY

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients

(2016) M. Sandstrom et al.   JOURNAL OF NUCLEAR MEDICINE

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer

(2016) Richard Laforest et al.   MOLECULAR IMAGING AND BIOLOGY

Microarray Based Screening of Peptide Nano Probes for HER2 Positive Tumor

(2015) Zihua Wang et al.   ANALYTICAL CHEMISTRY

Role of Imaging in Neoadjuvant Therapy for Breast Cancer

(2015) Vandana Dialani et al.   ANNALS OF SURGICAL ONCOLOGY

Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2

(2015) Bishnu P. Joshi et al.   BIOCONJUGATE CHEMISTRY

An Exploratory Study on 99mTc-RGD-BBN Peptide Scintimammography in the Assessment of Breast Malignant Lesions Compared to 99mTc-3P4-RGD2

(2015) Qianqian Chen et al.   PLoS One

Molecular and Cellular Heterogeneity in Breast Cancer

(2013) Ashley G. Rivenbark et al.   AMERICAN JOURNAL OF PATHOLOGY

Trastuzumab for patients with HER2 positive breast cancer: Delivery, duration and combination therapies

(2013) Ana Catarina Pinto et al.   BREAST

HER2 testing: Current status and future directions

(2013) Edith A. Perez et al.   CANCER TREATMENT REVIEWS

Current Status of Anti–Human Epidermal Growth Factor Receptor 2 Therapies: Predicting and Overcoming Herceptin Resistance

(2013) Alice Chung et al.   Clinical Breast Cancer

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

99mTc-Labeled Dimeric Octreotide Peptide: A Radiotracer with High Tumor Uptake for Single-Photon Emission Computed Tomography Imaging of Somatostatin Receptor Subtype 2-Positive Tumors

(2013) Chengyan Dong et al.   MOLECULAR PHARMACEUTICS

Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach

(2012) Enrica Calce et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

(2012) B. B. Koolen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

99mTc-Labeled RGD-BBN Peptide for Small-Animal SPECT/CT of Lung Carcinoma

(2012) Zhaofei Liu et al.   MOLECULAR PHARMACEUTICS

HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies

(2011) Devika Gajria et al.   Expert Review of Anticancer Therapy

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

(2010) David Groheux et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

(2008) Kristin McLarty et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

(2008) S. Ueda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Imaging and cancer: A review

(2008) Leonard Fass   Molecular Oncology